Multicenter evaluation of four homogenous LDL-cholesterol assays;Évaluation multicentrique de quatre méthodes de dosage direct du cholestérol-LDL

Annales de Biologie Clinique

Volumn 63, Issue 1, 2005, Pages 27-41

  Bayer, P ^a   Veinberg, F ^b   Couderc, R ^b   Cherfils, C ^c   Cambillau, M ^c   Cosson, C ^d   Fradin, S ^e   Gillery, P ^f   Steinmetz, J ^g   Legrand, A ^d   Egloff, M ^c   Beucler, I ^c  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b ARMAND TROUSSEAU HOSPITAL   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d BICÊTRE HOSPITAL   (France)

^e CHU CÔTE DE NACRE   (France)

^f SERVICE DE DERMATOLOGIE   (France)

^g Centre de Medecine Preventive   (France)

Author keywords

Direct assays; Homogeneous assays; LDL cholesterol

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; BLOOD; BLOOD ANALYSIS; CLINICAL TRIAL; COMPARATIVE STUDY; HUMAN; HYPERLIPOPROTEINEMIA; LABORATORY; METHODOLOGY; MULTICENTER STUDY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

BLOOD CHEMICAL ANALYSIS; CHOLESTEROL; CHOLESTEROL, LDL; HUMANS; HYPERLIPOPROTEINEMIAS; LABORATORIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TRIGLYCERIDES;

EID: 13644261524     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality : 30 years of follow-up from the Framingham study. JAMA 1987 ; 257 : 2176-80.
2. Kannel WB, Neaton JD, Wentworth D, et al. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple risk factor intervention trial. Am Heart J 1986 ; 112 : 825-36.
3. Scandinavian simvastatin survival study group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease : the Scandinavian simvastatin survival study (4S). Lancet 1994 ; 344 : 1383-9.
4. The lipid research clinics coronary primary prevention trial results. I. Reduction in incidence of coronary heart disease. JAMA 1984 ; 251 : 351-64.
5. Executive summary of the third report of the National cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment Panel III). JAMA 2001 ; 285 : 2486-97.
6. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972 ; 18 : 499-502.
7. Warnick GR, Knopp RH, Fitzpatrick V, Branson L. Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin Chem 1990 ; 36 : 15-9.
8. Bachorik PS, Ross JW. National cholesterol education program recommendations for measurement of low-density cholesterol : executive summary. The national cholesterol education program working group on lipoprotein measurement. Clin Chem 1995 ; 41 : 1414-20.
9. Jialal I, Hirany SV, Devaraj S, Sherwood TA. Comparison of an immunoprecipitation method for direct measurement of LDL-cholesterol with beta-quantification (ultracentrifugation). Am J Clin Pathol 1995 ; 104 : 76-81.
10. McNamara JR, Cohn JS, Wilson PW, Schaefer EJ. Calculated values for low-density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk. Clin Chem 1990 ; 36 : 36-42.
11. Couderc R, Beucler I, Bruckert E, et al. Comparaison du calcul du LDL-cholestérol par la formule de Friedewald et par celle de Planella. Le Courrier de l'Arcol 1999 ; 1 : 79-81.
12. Rubies-Prat J, Reverter JL, Senti M, et al. Calculated low-density lipoprotein cholesterol should not be used for management of lipoprotein abnormalities in patients with diabetes mellitus. Diabetes Care 1993 ; 16: 1081-6.
13. Hirany S, Li D, Jialal I. A more valid measurement of low-density lipoprotein cholesterol in diabetic patients. Am J Med 1997 ; 102 : 48-53.
14. Johnson R, McNutt P, MacMahon S, Robson R. Use of the Friedewald formula to estimate LDL-cholesterol in patients with chronic renal failure on dialysis. Clin Chem 1997 ; 43 : 2183-4.
15. Bairaktari E, Elisaf M, Tzallas C, et al. Evaluation of five methods for determining low-density lipoprotein cholesterol (LDL-C) in hemodialysis patients. Clin Biochem 2001 ; 34 : 593-602.
16. Egloff M, Léglise D, Duvillard L, et al. Évaluation multicentrique sur différents automates d'analyses de trois méthodes de dosage direct du cholestérol-HDL. Ann Biol Clin 1999 ; 57 : 561-72.
17. Warnick GR, Nauck M, Rifai N. Evolution of methods for measurement of HDL-cholesterol : from ultracentrifugation to homogeneous assays. Clin Chem 2001 ; 47 : 1579-96.
18. Rifai N, Warnick GR, McNamara JR, Belcher JD, Grinstead GF, Frantz ID Jr. Measurement of low-density-lipoprotein cholesterol in serum : a status report. Clin Chem 1992 ; 38 : 150-60.
19. Yu HH, Ginsburg GS, Harris N, Rifai N. Evaluation and clinical application of a direct low-density lipoprotein cholesterol assay in normolipidemic and hyperlipidemic adults. Am J Cardiol 1997 ; 80 : 1295-9.
20. Planella T, Cortes M, Martinez-Bru C, Gonzalez-Sastre F, Ordonez-Llianos J. Calculation of LDL-cholesterol by using apolipoprotein B for classification of nonchylomicronemic dyslipemia. Clin Chem 1997 ; 43 : 808-15.
21. Marcovina SM, Albers JJ, Kennedy H, Mei JV, Henderson LO, Hannon WH. International federation of clinical chemistry standardization project for measurements of apolipoproteins A-I and B. Comparability of apolipoprotein B values by use of International reference material. Clin Chem 1994 ; 40 : 586-92.
22. Nauck M, Warnick GR, Rifai N. Methods for measurement of LDL-cholesterol : a critical assessment of direct measurement by homogeneous assays versus calculation. Clin Chem 2002 ; 48 : 236-54.
23. Sich D, Saidi Y, Egloff M, et al. Direct isolation of labeled low density lipoproteins for the determination of cholesteryl ester transfer protein activity. Clin Chim Acta 1997 ; 266 : 185-93.
24. Commission de standardisation lipides-lipoprotéines Arcol/SFBC. Recommandations pratiques pour le dosage du cholestérol-HDL après précipitation par le phosphotungstate de sodium et le chlorure de magnésium. Option Bio 1996 ; 172 (Suppl.) : 1-6.
25. Warnick GR, Myers GL, Cooper GR, Rifai N. Impact of the third cholesterol report from the adult treatment panel of the national cholesterol education program on the clinical laboratory. Clin Chem 2002 ; 48 : 11-7.
26. Morganroth J, Levy RI, Fredrickson DS. The biochemical, clinical and genetic features of type III hyperlipoproteinemia. Ann Intern Med 1975 ; 82 : 158-74.
27. Service des recommandations et références professionnelles. Modalités de dépistage et diagnostic biologique des dyslipidémies en prévention primaire. Anaes. Octobre 2000.
28. Nauck M, Graziani MS, Bruton D, et al. Analytical and clinical performance of a detergent-based homogeneous LDL-cholesterol assay : a multicenter evaluation. Clin Chem 2000 ; 46 : 506-14.
29. Smets EM, Pequeriaux NC, Blaton V, Goldschmidt HM. Analytical performance of a direct assay for LDL-cholesterol. Clin Chem Lab Med 2001 ; 39 : 270-80.
30. Miller WG, Waymack PP, Anderson FP, Ethridge SF, Jayne EC. Performance of four homogeneous direct methods for LDL-cholesterol. Clin Chem 2002 ; 48 : 489-98.
31. Esteban-Salan M, Guimon-Bardesi A, De la Viuda-Unzueta JM, Azcarte-Ania MN, Pascual-Usandizaga P, Amoroto-Del-Rio E. Analytical and clinical evaluation of two homogeneous assays for LDL-cholesterol in hyperlipidemic patients. Clin Chem 2000 ; 46 : 1121-31.
32. Okada M, Matsui H, Ito Y, Fujiwara A, Inano K. Low-density lipoprotein cholesterol can be chemically measured : a new superior method. J Lab Clin Med 1998 ; 132 : 195-201.
33. 2+ method. Clin Chem 1998 ; 44 : 1242-50.
34. Sakaue T, Hirano T, Yoshimo G, Sakai K, Takeuchi H, Adachi M. Reactions of direct LDL-cholesterol assays with pure LDL fraction and IDL : comparison of three homogeneous methods. Clin Chim Acta 2000 ; 295 : 97-106.
35. Usui S, Kakuuchi H, Okamoto M, Mitzukami Y, Okazaki M. Differential reactivity of two homogeneous LDL-cholesterol methods to LDL and VLDL subfractions, as demonstrated by ultracentrifugation and HPLC. Clin Chem 2002 ; 48 : 1946-54.
36. Fei H, Maeda S, Kirii H, et al. Evaluation of two different homogeneous assays for LDL-cholesterol in lipoprotein-X-positive serum. Clin Chem 2000 ; 46 : 1351-6.
37. Horiuchi Y, Takanohashi K, Oikawa S, Numabe A, Hishinuma A, Ieiri T. Measurement of serum low density lipoprotein-cholesterol in patients with hypertriglycemia. Electrophoresis 2000 ; 21 : 293-6.
38. Wagner AM, Zapico E, Bonet R, Perez A, Ordonez-Llianos J. The effect of VLDL particles on the accuracy of a direct LDL-cholesterol method in type 2 diabetic patients. Clin Biochem 2003 ; 36 : 177-83.